TABLE 1.
Number of animals (eyes) examined in the various models
Route of administration |
Intravitreous * | Systemic † | |||
---|---|---|---|---|---|
Model | Total animals | Flatmount | Cryosection | Flatmount | Cryosection |
OIR | 8 | 8 (16) | ND | ND | ND |
I/R‡ | 20§ | 6 (6) | 4 (4) | 6 (12) | 4 (8) |
STZ-induced diabetic mice | 12§ | 4 (4) | 2 (2) | 4 (8) | 2 (4) |
Normal control mice | 12§ | 4 (4) | 2 (2) | 4 (8) | 2 (4) |
BBZDR/Wor diabetic rats | 12§ | 12 (12) | ND | ND | ND |
BBZDR/Wor control rats | 12§ | 12 (12) | ND | ND | ND |
One eye from each animal received cells by intravitreous injection.
Both eyes from each animal were included for analysis.
One eye from each animal was injured and given cells by intravitreous injection; the contralateral eye was used as unaffected control.
Animals were divided equally to receive huEPCs of either nondiabetic or diabetic origin. ND, not done.